You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Claims for Patent: 7,553,863


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,553,863
Title:Ultrapure 4-methylpyrazole
Abstract:Disclosed is an ultrapure 4-methylpyrazole containing less than 0.1% pyrazole and containing less than 10 ppm each of hydrazine and nitrobenzaldehyde. The ultrapure 4-methylpyrazole is prepared by a novel process so that less than 0.01% of ethylvinyl ether is present.
Inventor(s): Reardan; Dayton T. (Shorewood, MN), Combe; Michel D. (Fox Point, WI)
Assignee: Paladin Labs (Barbados) Inc. (Barbados, BB)
Application Number:11/279,708
Patent Claims: 1. A solution containing 4-methyl pyrazole containing less than 0.1% pyrazole.

2. The solution of claim 1 containing less than 10 ppm each of hydrazine and nitrobenzaldehyde.

3. The solution of claim 2, wherein the nitrobenzaldehyde is p-nitrobenzaldehyde.

4. A process of making 4-methylpyrazole containing less than 0.1% pyrazole comprising the steps: (a) reacting propionaldehyde with triethyl orthoformate to produce 1,1-diethoxypropane; (b) reacting the 1,1-diethoxypropane of step (a) with an amine and an acid at a temperature of about 140-160.degree. C. to produce 1-ethoxy-1-propene; (c) washing the 1-ethoxy-1-propene with water and drying it without distillation; (d) reacting the dried 1-ethoxy-1-propene of step (c) with triethyl orthoformate in the presence of a catalytic amount of boron trifluoride-diethyl etherate to produce 1,1,3,3-tetraethoxy-2-methylpropane; and (e) reacting the 1,1,3,3-tetraethoxy-2-methylpropane of step (d) with hydrazine or a hydrazonium salt to produce 4-methylpyrazole containing less than 0.1% pyrazole.

5. A process of making 4-methylpyrazole containing less than 0.1% pyrazole and less than 10 ppm each of hydrazine and nitrobenzaldehyde comprising the steps: (a) reacting propionaldehyde with triethyl orthoformate to produce 1,1-diethoxypropane; (b) reacting the 1,1-diethoxypropane of step (a) with an amine and an acid at a temperature of about 140-160.degree. C. to produce 1-ethoxy-1-propene; (c) washing the 1-ethoxy-1-propene with water and drying it without distillation; (d) reacting the dried 1-ethoxy-1-propene of step (c) with triethyl orthoformate in the presence of a catalytic amount of boron trifluoride-diethyl etherate to produce 1,1,3,3-tetraethoxy-2-methylpropane; and (e) reacting the 1,1,3,3-tetraethoxy-2-methylpropane of step (d) with hydrazine or a hydrazonium salt to produce 4-methylpyrazole containing less than 0.1% pyrazole and less than 10 ppm each of hydrazine and nitrobenzaldehyde.

6. The process of claim 4 or 5 wherein the molar ratio of acid to amine is about 1:0.4-0.6.

7. The process of claim 6 wherein the reaction temperature is about 160.degree. C.

8. The process of claim 4 or 5 wherein the 1-ethoxy-1-propene of step (b) is dried over a drying agent in step (c).

9. The process of claim 8 wherein the drying agent is magnesium sulfate.

10. The process of claim 4 or 5 wherein the dried 1-ethoxy-1-propene of step (c) contains less than 0.01% ethylvinyl ether.

11. The process of claim 10 wherein less than 0.01% ethylvinyl ether is present in the dried 1-ethoxy-1-propene of step (c) as a result of the molar ratio of acid to amine, the reaction temperature, and the washing and drying of the product without distillation.

12. The process of claim 4 or 5 wherein in step (e) a slight molar excess of 1,1,3,3-tetraethoxy-2-methylpropane is used relative to the hydrazine or hydrazonium salt.

13. The process of claim 12 wherein the molar excess is about 0.1% to about 0.5%.

14. The process of any one of claims 4, 5 or 12 wherein a hydrazonium salt is used in step (e).

15. The process of claim 14 wherein the hydrazonium salt is hydrazine hydrosulfate.

16. A composition consisting essentially of 4-methyl pyrazole containing less than 0.1% pyrazole.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.